The present study has been approved by the Committee on Animal Research and Ethics (CARE), Universiti Technologi MARA (UiTM) [Reference No: UiTM CARE 346/2021, dated 7 May 2021].
NOTE: The published protocols22,25,26 for standard husbandry and maintenance of the 6-OHDA-lesioned adult zebrafish PD model were utilized. Experiments were conducted with adult male zebrafish (Danio rerio) aged more than five months old with a standardized length of 3.2-3.7 cm.
1. Zebrafish maintenance and pre-ICV microinjection preparations
2. Anaesthetisation and ICV injection of zebrafish
Figure 1: Injection site of neurotoxin, 6-OHDA. (A) The point of microcapillary entry is guided by the intersection between the metopic suture (MS), coronal suture (CS), and sagittal suture (SS) that connects the frontal and parietal skull of the zebrafish brain (plan view). (B) A schematic drawing (plan view) of the zebrafish skull and brain shows the microcapillary, which is lowered directly above the habenula (Hab), and its point of entry at the intersection between hemispheres. (C) A schematic drawing (sagittal section) of the zebrafish brain shows the angle of injection and depth of penetration. The black dot represents the lesioned site that is situated above the targeted area, the ventral diencephalon. Abbreviations: 6-OHDA: 6-hydroxydopamine, CS: coronal suture, Dn: diencephalon, Hab: habenula, Hyp: hypothalamus, MS: metopic suture, OB: olfactory bulb, POA: preoptic area, PT: posterior tuberculum, SS: sagittal suture, Tec: tectum, and Tel: telencephalon. Please click here to view a larger version of this figure.
3. Locomotor assessment
NOTE: Locomotor assessment of zebrafish (n = six / group; sham vs lesioned) was assessed individually via the open tank test using established protocols28,29 at day three and day 30 post-6-OHDA lesion.
Figure 2: Experimental setup of an open tank test for assessment of zebrafish locomotor behavior. (A) The experimental tank (front view) is placed on a raised platform that is illuminated from below. The four walls of the tank are covered with white paper and the recordings are captured axially. The temperature is measured using a thermometer and regulated at 28 ± 1.0 °C using a commercial aquarium heater. (B) Screenshot (plan view) of video recording that is captured using the setup. Please click here to view a larger version of this figure.
The present experiment assessed the changes in adult zebrafish swimming behavior following ICV microinjection with 6-OHDA. The reason for using 6-OHDA as the neurotoxin of choice was due to its inability to cross the blood-brain barrier, which produced specific and targeted ablation of DpN in the area of interest-ventral diencephalon (Dn)16. The DpN subpopulation here holds anatomical resemblance to the DpN subpopulation in the human's substantia nigra pars compacta31.
As per our previous work22, the cellular effect of 6-OHDA ICV microinjection against DpN of adult zebrafish was confirmed through immunohistostaining of DpN marker-tyrosine hydroxylase (TH). The main brain region of interest was the Dn, made up of the preoptic area (POA), posterior tuberculum (PT), and hypothalamus (Hyp). It was found that 99.96 mM 6-OHDA resulted in a 100% survival rate of the adult zebrafish with the lowest number of TH-immunoreactive (TH-ir) in Dn. It was also found that more than 85% (p < 0.01) of TH-ir DpN in the Dn was ablated on day three postlesion. The number of TH-ir DpN then increased by more than 50% at day 14 postlesion before achieving full regeneration 30 days postlesion (Figure 3). This data supports the regenerative capabilities of DpN subpopulation in Dn of adult zebrafish following ablation32.
Figure 3: Regeneration of DpN in the Dn region of zebrafish lesioned by 99.96 mM 6-OHDA. (A) The number of TH-ir DpN in three main areas of the Dn region, POA, PT, and Hyp, over four data points: sham, 3, 14, and 30 days post-lesioning by 99.96 mM 6-OHDA neurotoxin. Each bar represents mean ± SD of n = 6 independent experiments; *p < 0.05. (B) Representative confocal microscope images of sagittally sectioned zebrafish brain of sham (I, I', and I''), 3 days post-lesioning (II, II', and II''), 14 days post-lesioning (III, III', and III''), and 30 days post-lesioning (IV, IV', and IV'') stained with TH (DpN; green) and DAPI (nuclei; blue). Scale bar = 50 µm. Abbreviations- DAPI: 4′, 6-diamidino-2-phenylindole, 6-OHDA: 6-hydroxydopamine, Dn: diencephalon, DpN: dopaminergic neurons, Hyp: hypothalamus, POA: preoptic area, PT: posterior tuberculum, SD: standard deviation, and TH-ir: tyrosine hydroxylase immunoreactive. Adapted from Vijayanathan et al.22. Please click here to view a larger version of this figure.
We then performed locomotor assessment using the open tank test to investigate changes in distance traveled (cm) and mean speed (cm/s) of adult zebrafish following ICV microinjection of 6-OHDA and sham. Experimental fish were then assessed on day three postlesion (least number of TH-ir DpN observed) and day 30 postlesion (fully restored DpN reported at lesion site). Analysis of zebrafish swimming behavior using a video tracking software indicated that both the mean speed (cm/s) and distance traveled (cm) of the lesioned group on day three postlesion were significantly reduced (p < 0.001) to <45% when compared to sham (Figure 4). The lesioned group exhibited recovery of motor function 30 days postlesion with no significant difference of both the mean speed (cm/s) and distance traveled (cm) when compared to sham.
Figure 4: Changes in swimming behavior following intracerebroventricular injection by 6-OHDA. Swimming behavior of adult zebrafish was assessed before lesioning, on day three and day 30 postlesion by 99.96 mM 6-OHDA. Parameters that were assessed included: (A) mean speed (cm/s) and (B) distance traveled (cm). Each bar represents mean ± SD of six fish; ****p < 0.0001 (Student t-test). Abbreviations: 6-OHDA: 6-hydroxydopamine, SD: standard deviation. Please click here to view a larger version of this figure.
Materials | |||
6-Hydroxydopamine (6-OHDA) | Sigma-Aldrich, Missouri, USA | 162957 | |
Ascorbic acid | Thermo Fisher Scientific, California, USA | FKC#A/8882/53 | |
Disposable pasteur pipette, 3 mL | Thermo Fisher Scientific, California, USA | FB55348 | |
Microcentrifuge tube, 0.2 mL | Eppendorf, Hamburg, Germany | 30124332 | |
Nice conical flask, 100 mL | Evergreen Engineering & Resources, Semenyih, Malaysia | SumYau0200 | |
Phosphate buffered saline (PBS) | Sigma-Aldrich, Missouri, USA | P4417 | |
Sodium bicarbonate | Sigma-Aldrich, Missouri, USA | S5761 | |
Sodium chloride | Merck, Darmstadt, Germany | 106404 | |
Stereomicroscope | Nikon, Tokyo, Japan | SMZ745 | |
Tricaine methanesulfonate (MS-222) | Sigma-Aldrich, Missouri, USA | E10521 | |
Equipment | |||
ANY-maze software | Stoelting Co., Illinois, USA | – | version 7.0; video tracking software |
Cubis II Micro Lab Balance | Sartorius, Göttingen, Germany | SE 2 | |
FemtoJet IV microinjector | Eppendorf, Hamburg, Germany | 5192000035 | |
Femtotip II, sterile injection capillary | Eppendorf, Hamburg, Germany | 5242957000 | |
InjectMan 4 micromanipulator | Eppendorf, Hamburg, Germany | 5192000027 | |
LED Portable Lamp | MR. DIY, Selangor, Malaysia | 9023251 | 20 mAh |
PELCO Pro Superalloy, offset, fine tips | Ted Pella, California, USA | 5367-12NM | |
Shanda aquarium heater | Yek Fong Aquarium, Selangor, Malaysia | SDH-228 | |
Thermometer | Sera Precision, Heinsberg, Germany | 52525 | |
Video camera | Nikon, Tokyo, Japan | D3100 |
The limitations of current treatments in delaying dopaminergic neuronal loss in Parkinson's disease (PD) raise the need for alternative therapies that can restore these neurons. Much effort is currently directed toward a better understanding of neuroregeneration using preclinical in vivo models. This regenerative capability for self-repair is, however, inefficient in mammals. Non-mammalian animals like zebrafish have thus emerged as an excellent neuroregenerative model due to its capability to continuously self-renew and have a close brain homology to humans. As part of the effort in elucidating cellular events involved in neuroregeneration in vivo, we have established the 6-hydroxydopamine (6-OHDA)-induced adult zebrafish-based PD model. This was achieved through the optimized intracerebroventricular (ICV) microinjection of 99.96 mM 6-OHDA to specifically ablate dopaminergic neurons (DpN) in the ventral diencephalon (Dn) of zebrafish brain. Immunofluorescence indicated more than 85% of DpN ablation at day three postlesion and full restoration of DpN at lesioned site 30 days postlesion. The present study determined the impairment and subsequent recovery of zebrafish swimming behavior following lesion by using the open field test through which two parameters, distance traveled (cm) and mean speed (cm/s), were quantified. The locomotion was assessed by analyzing the recordings of individual fish of each group (n = 6) using video tracking software. The findings showed a significant (p < 0.0001) reduction in speed (cm/s) and distance traveled (cm) of lesioned zebrafish 3 days postlesion when compared to sham. The lesioned zebrafish exhibited full recovery of swimming behavior 30 days postlesion. The present findings suggest that 6-OHDA lesioned adult zebrafish is an excellent model with reproducible quality to facilitate the study of neuroregeneration in PD. Future studies on the mechanisms underlying neuroregeneration as well as intrinsic and extrinsic factors that modulate the process may provide important insight into new cell replacement treatment strategies against PD.
The limitations of current treatments in delaying dopaminergic neuronal loss in Parkinson's disease (PD) raise the need for alternative therapies that can restore these neurons. Much effort is currently directed toward a better understanding of neuroregeneration using preclinical in vivo models. This regenerative capability for self-repair is, however, inefficient in mammals. Non-mammalian animals like zebrafish have thus emerged as an excellent neuroregenerative model due to its capability to continuously self-renew and have a close brain homology to humans. As part of the effort in elucidating cellular events involved in neuroregeneration in vivo, we have established the 6-hydroxydopamine (6-OHDA)-induced adult zebrafish-based PD model. This was achieved through the optimized intracerebroventricular (ICV) microinjection of 99.96 mM 6-OHDA to specifically ablate dopaminergic neurons (DpN) in the ventral diencephalon (Dn) of zebrafish brain. Immunofluorescence indicated more than 85% of DpN ablation at day three postlesion and full restoration of DpN at lesioned site 30 days postlesion. The present study determined the impairment and subsequent recovery of zebrafish swimming behavior following lesion by using the open field test through which two parameters, distance traveled (cm) and mean speed (cm/s), were quantified. The locomotion was assessed by analyzing the recordings of individual fish of each group (n = 6) using video tracking software. The findings showed a significant (p < 0.0001) reduction in speed (cm/s) and distance traveled (cm) of lesioned zebrafish 3 days postlesion when compared to sham. The lesioned zebrafish exhibited full recovery of swimming behavior 30 days postlesion. The present findings suggest that 6-OHDA lesioned adult zebrafish is an excellent model with reproducible quality to facilitate the study of neuroregeneration in PD. Future studies on the mechanisms underlying neuroregeneration as well as intrinsic and extrinsic factors that modulate the process may provide important insight into new cell replacement treatment strategies against PD.
The limitations of current treatments in delaying dopaminergic neuronal loss in Parkinson's disease (PD) raise the need for alternative therapies that can restore these neurons. Much effort is currently directed toward a better understanding of neuroregeneration using preclinical in vivo models. This regenerative capability for self-repair is, however, inefficient in mammals. Non-mammalian animals like zebrafish have thus emerged as an excellent neuroregenerative model due to its capability to continuously self-renew and have a close brain homology to humans. As part of the effort in elucidating cellular events involved in neuroregeneration in vivo, we have established the 6-hydroxydopamine (6-OHDA)-induced adult zebrafish-based PD model. This was achieved through the optimized intracerebroventricular (ICV) microinjection of 99.96 mM 6-OHDA to specifically ablate dopaminergic neurons (DpN) in the ventral diencephalon (Dn) of zebrafish brain. Immunofluorescence indicated more than 85% of DpN ablation at day three postlesion and full restoration of DpN at lesioned site 30 days postlesion. The present study determined the impairment and subsequent recovery of zebrafish swimming behavior following lesion by using the open field test through which two parameters, distance traveled (cm) and mean speed (cm/s), were quantified. The locomotion was assessed by analyzing the recordings of individual fish of each group (n = 6) using video tracking software. The findings showed a significant (p < 0.0001) reduction in speed (cm/s) and distance traveled (cm) of lesioned zebrafish 3 days postlesion when compared to sham. The lesioned zebrafish exhibited full recovery of swimming behavior 30 days postlesion. The present findings suggest that 6-OHDA lesioned adult zebrafish is an excellent model with reproducible quality to facilitate the study of neuroregeneration in PD. Future studies on the mechanisms underlying neuroregeneration as well as intrinsic and extrinsic factors that modulate the process may provide important insight into new cell replacement treatment strategies against PD.